Ind-Swift Laboratories Limited
NSE: INDSWFTLAB BSE: INDSWFTLAB
NSE
102.00
0.29 (0.29%)
Prev Close
101.71
Open Price
104.8
Volume
38,022
Today Low / High
102 / 104.8
52 WK Low / High
68.72 / 134.4
Range
97 - 107
BSE
102.00
0.73 (0.72%)
Prev Close
101.27
Open Price
105.76
Volume
3,182
Today Low / High
101.5 / 105.76
52 WK Low / High
67.15 / 133
Range
97 - 107
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 102 (target range: 97 - 107), reflecting a change of 0.29 (0.28512%). On the BSE, it is listed at 102 (target range: 97 - 107), showing a change of 0.73 (0.72085%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
07 Oct
104.80
-2.67%
06 Oct
97.00
4.86%
03 Oct
96.10
1.19%
01 Oct
97.20
0.17%
30 Sep
96.10
-0.91%
29 Sep
100.00
-3.92%
26 Sep
102.00
-2.03%
25 Sep
104.94
-1.63%
24 Sep
103.89
-0.24%
23 Sep
105.78
-1.78%
22 Sep
105.88
-1.45%
19 Sep
104.06
0.04%
18 Sep
106.93
-1.05%
17 Sep
106.00
-0.59%
16 Sep
107.44
-2.22%
15 Sep
108.00
-2.17%
12 Sep
108.00
-2.16%
11 Sep
111.90
-3.20%
10 Sep
109.00
1.07%
09 Sep
108.85
-0.38%
Ind-Swift Laboratories Limited Graph
Ind-Swift Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Ind-Swift Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 102.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 102.00 | 103.02 | 92.72 - 113.32 |
| 104.04 | 83.23 - 124.85 | ||
| 105.06 | 73.54 - 136.58 | ||
| Bearish Scenario | 102.00 | 100.98 | 90.88 - 111.08 |
| 99.96 | 79.97 - 119.95 | ||
| 98.94 | 69.26 - 128.62 |
Overview of Ind-Swift Laboratories Limited
ISIN
INE915B01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
76,703
Market Cap
6,892,592,778
Last Dividend
0
Official Website
IPO Date
2002-07-01
DCF Diff
2.29
DCF
99
Financial Ratios Every Investor Needs
Stock Dividend of INDSWFTLAB
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2011-09-20 | September 20, 11 | 1 | 1 | 2011-09-21 | 2011-10-26 | 2011-05-25 |
| 2010-09-16 | September 16, 10 | 1 | 1 | 2010-09-18 | 2010-10-22 | 2010-05-29 |
| 2009-09-17 | September 17, 09 | 1 | 1 | 2009-09-19 | 2009-10-24 | 2009-06-29 |
| 2008-09-18 | September 18, 08 | 1 | 1 | 2008-09-22 | 2008-11-01 | 2008-06-19 |
| 2007-09-21 | September 21, 07 | 1 | 1 | 2007-09-25 | 2007-11-01 | 2007-07-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 561.71 Cr | 287.95 Cr | 273.76 Cr | 0.4874 | 2.30 Cr | 119.16 Cr | -43.87 Cr | 250.48 Cr | 37.25 | 285.20 Cr | 0.4459 |
| 2024-03-31 | 1,280.90 Cr | 867.58 Cr | 413.32 Cr | 0.3227 | 35.52 Cr | 36.78 Cr | 200.90 Cr | 420.96 Cr | 91.18 | 782.41 Cr | 0.3286 |
| 2023-03-31 | 1,207.31 Cr | 766.86 Cr | 440.45 Cr | 0.3648 | 42.57 Cr | 20.52 Cr | 181.52 Cr | 47.60 Cr | 8.06 | 235.77 Cr | 0.0394 |
| 2022-03-31 | 1,038.73 Cr | 629.12 Cr | 409.61 Cr | 0.3943 | 32.72 Cr | 20.41 Cr | 92.42 Cr | -2.15 Cr | -0.36 | 239.12 Cr | -0.0021 |
| 2021-03-31 | 891.34 Cr | 516.24 Cr | 375.10 Cr | 0.4208 | 33.01 Cr | 15.95 Cr | 110.96 Cr | -3.15 Cr | -0.53 | 198.25 Cr | -0.0035 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 428.04 Cr | 1,438.34 Cr | 265.37 Cr | 1,172.9997 Cr | 40.84 Cr | -387.20 Cr | 114.18 Cr | 260.07 Cr | 0.00 Cr | 0.00 Cr | 252.00 Cr | 220.5801 Cr |
| 2024-03-31 | 493.81 Cr | 1,460.43 Cr | 648.37 Cr | 936.1773 Cr | 16.62 Cr | -415.31 Cr | 108.73 Cr | 5.36 Cr | 5.35 Cr | 0.00 Cr | 110.54 Cr | 216.5571 Cr |
| 2023-03-31 | 18.20 Cr | 1,824.06 Cr | 1,142.13 Cr | 681.9307 Cr | 862.10 Cr | 843.90 Cr | 438.60 Cr | 592.75 Cr | 0.00 Cr | 0.12 Cr | 25.38 Cr | 371.0889 Cr |
| 2022-03-31 | 21.48 Cr | 1,800.79 Cr | 1,199.93 Cr | 600.9723 Cr | 953.02 Cr | 931.54 Cr | 428.50 Cr | 636.84 Cr | 0.00 Cr | 0.15 Cr | 29.06 Cr | 334.4653 Cr |
| 2021-03-31 | 11.60 Cr | 1,818.45 Cr | 1,215.03 Cr | 603.5061 Cr | 1,005.35 Cr | 993.75 Cr | 375.67 Cr | 748.09 Cr | 0.00 Cr | 0.17 Cr | 27.23 Cr | 314.5231 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -25.4735 Cr | -109.6222 Cr | 69.2046 Cr | -89.8796 Cr | -66.4687 Cr | 427.4607 Cr | -64.4061 Cr | 34.5943 Cr | 20.9929 Cr | 0.0000 Cr | -43.1578 Cr |
| 2024-03-31 | -163.1152 Cr | -122.6903 Cr | 698.9138 Cr | -207.6321 Cr | 413.2799 Cr | 431.4797 Cr | -44.5169 Cr | 420.9616 Cr | -37.4278 Cr | 0.0000 Cr | 32.8866 Cr |
| 2023-03-31 | 194.6196 Cr | -13.3683 Cr | -185.6574 Cr | 181.8489 Cr | -4.4061 Cr | 17.0715 Cr | -12.7707 Cr | 113.1690 Cr | -45.9089 Cr | 0.0000 Cr | -10.1029 Cr |
| 2022-03-31 | 150.2741 Cr | 4.7722 Cr | -140.8769 Cr | 131.8592 Cr | 14.1694 Cr | 25.7700 Cr | -18.4149 Cr | 12.5324 Cr | -36.0118 Cr | 0.0000 Cr | -52.8337 Cr |
| 2021-03-31 | 134.9471 Cr | -10.1716 Cr | -123.7469 Cr | 130.5505 Cr | 1.0287 Cr | 11.6110 Cr | -3.9104 Cr | 18.0085 Cr | -39.8529 Cr | 0.0000 Cr | -32.8484 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 152.73 Cr | 73.09 Cr | 79.65 Cr | 0.5215 | 47.11 Cr | 8.77 Cr | 1.28 | 3.04 Cr | 0.0574 |
| 2025-03-31 | 507.92 Cr | 246.11 Cr | 261.82 Cr | 0.5155 | -7.09 Cr | 249.12 Cr | 42.16 | 283.31 Cr | 0.4905 |
| 2024-12-31 | 8.66 Cr | 6.22 Cr | 2.45 Cr | 0.2822 | -14.78 Cr | 0.01 Cr | 0.00 | -0.72 Cr | 0.0007 |
| 2024-09-30 | 11.96 Cr | 8.31 Cr | 3.64 Cr | 0.3048 | -12.01 Cr | 0.41 Cr | 0.07 | 1.21 Cr | 0.0346 |
| 2024-06-30 | 33.17 Cr | 33.65 Cr | -0.48 Cr | -0.0145 | -9.99 Cr | 0.94 Cr | 0.16 | 1.40 Cr | 0.0282 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 467.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,172.96 Cr |
| 2025-03-31 | 428.04 Cr | 39.37 Cr | 481.64 Cr | 164.52 Cr | 114.18 Cr | 865.35 Cr | 260.07 Cr | 1,438.34 Cr | 265.37 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 438.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,011.52 Cr |
| 2024-09-30 | 438.46 Cr | 0.00 Cr | 438.46 Cr | 57.55 Cr | 9.33 Cr | 586.80 Cr | 5.02 Cr | 1,188.02 Cr | 176.50 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 431.93 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -931.44 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 8.77 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 249.12 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.41 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,655.20 | ₹3,971,373,245,554.00 | ₹1,251,335.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,053.00 | ₹1,606,886,350,836.00 | ₹380,081.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,504.40 | ₹1,186,046,658,000.00 | ₹74,719.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,251.80 | ₹1,041,963,582,550.00 | ₹468,337.00 |
| Mankind Pharma Limited | MANKIND | ₹2,467.00 | ₹1,018,275,194,830.00 | ₹85,822.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.10 | ₹994,255,429,224.00 | ₹386,210.00 |
| Lupin Limited | LUPIN | ₹1,924.50 | ₹879,030,516,966.00 | ₹460,117.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,481.00 | ₹655,335,765,000.00 | ₹62,947.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,082.20 | ₹628,543,516,411.00 | ₹807,912.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,960.30 | ₹553,198,245,883.00 | ₹128,198.00 |
| Laurus Labs Limited | LAURUSLABS | ₹861.45 | ₹465,032,159,244.00 | ₹797,369.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,380.80 | ₹350,314,784,214.00 | ₹234,040.00 |
| Cohance Lifesciences Limited | COHANCE | ₹874.75 | ₹334,650,605,715.00 | ₹70,411.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,426.90 | ₹303,206,265,886.00 | ₹34,601.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,653.90 | ₹258,994,519,682.00 | ₹194,680.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,380.00 | ₹234,500,000,000.00 | ₹4,980.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,416.70 | ₹230,192,217,577.00 | ₹160,150.00 |
| Eris Lifesciences Limited | ERIS | ₹1,617.80 | ₹220,366,287,661.00 | ₹77,691.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹15,657.00 | ₹200,877,572,073.00 | ₹39,776.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹917.90 | ₹180,425,291,520.00 | ₹68,410.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,091.90 | ₹173,121,601,050.00 | ₹43,976.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,004.00 | ₹152,327,438,784.00 | ₹34,851.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹811.50 | ₹145,347,659,505.00 | ₹171,724.00 |
| Granules India Limited | GRANULES | ₹554.35 | ₹134,509,543,965.00 | ₹369,203.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,235.00 | ₹103,497,146,770.00 | ₹4,643.00 |
| Strides Pharma Science Limited | STAR | ₹831.85 | ₹76,673,872,141.00 | ₹134,574.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹829.90 | ₹75,216,300,973.00 | ₹81,377.00 |
| FDC Limited | FDC | ₹454.60 | ₹74,013,464,186.00 | ₹30,736.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹367.70 | ₹71,915,433,743.00 | ₹209,589.00 |
| Sequent Scientific Limited | SEQUENT | ₹201.50 | ₹50,357,439,074.00 | ₹437,390.00 |
| Innova Captab Limited | INNOVACAP | ₹836.05 | ₹47,842,901,890.00 | ₹3,682.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹499.25 | ₹45,566,547,500.00 | ₹34,246.00 |
| Suven Life Sciences Limited | SUVEN | ₹204.55 | ₹44,600,224,571.00 | ₹69,492.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹131.03 | ₹42,522,063,676.00 | ₹91,607.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,276.10 | ₹37,644,452,042.00 | ₹3,475.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹734.10 | ₹37,232,894,981.00 | ₹8,627.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹355.05 | ₹35,605,303,755.00 | ₹7,613.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹478.80 | ₹33,710,273,100.00 | ₹3,667.00 |
| Hikal Limited | HIKAL | ₹251.00 | ₹30,948,488,250.00 | ₹83,614.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹103.20 | ₹30,292,039,032.00 | ₹745,052.00 |
| Indoco Remedies Limited | INDOCO | ₹293.80 | ₹27,077,020,789.00 | ₹44,925.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹48.42 | ₹26,531,918,106.00 | ₹876,023.00 |
| Alembic Limited | ALEMBICLTD | ₹101.53 | ₹26,071,058,997.00 | ₹139,583.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹598.35 | ₹25,590,202,883.00 | ₹76,023.00 |
Key Executives
Executive Director
Mr. Sahil Munjal
Gender: male
Year Born: 1980
Senior Vice President of Marketing
Varun Chhabra
Gender: Not Specified
Year Born:
Chief Financial Officer
Mr. Gagan Aggarwal
Gender: male
Year Born:
Group HR Head
Akashdeep Sharma
Gender: Not Specified
Year Born:
Executive Director
Mr. Rishav Mehta
Gender: male
Year Born: 1991
General Manager of Information & Technology
Ashok Kothari
Gender: Not Specified
Year Born:
Joint MD & Whole Time Director
Mr. Himanshu Jain BCom
Gender: male
Year Born: 1982
Chairman & MD
Mr. Navrattan R. Munjal
Gender: male
Year Born: 1952
Vice President of Corporate Affairs, Compliance Officer & Company Secretary
Mr. Pardeep Verma
Gender: male
Year Born:
FAQs about Ind-Swift Laboratories Limited
Who is the CEO of the company?
The CEO is Navrattan R. Munjal.
What is the current market price of the stock?
The current price is ₹102.00.
What is the 52-week price range?
The range is ₹68.72-134.4.
What is the market capitalization of the company?
The market capitalization is ₹689.26 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 2.96.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Ind-Swift Laboratories Limited (ISIN: INE915B01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹689.26 crores and an average daily volume of 76,703 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.